Trading A Silver Collapse

No One Expects The ‘Spanish Inquisition

No one expects the Spanish Inquisition like no one expects a collapse in silver.

From a contrarian standpoint, just because it’s not expected does not in itself, mean it’s going to happen.

However, this site’s been building a strategic premise for years, food supplies come first then precious metals (not advice, not a recommendation).

Here are links that span over two-years; successively building on the case, we’re (potentially) in a ‘Genesis 41‘ situation first more than a Wimar Republic event.

Corn Flattened

“Ten percent of the U.S corn crop was instantly wiped out last week during what’s described as an inland hurricane.”

‘Stacking’ … Strategic Error ?

“As we continue on, it’s becoming clear that single-mindedly stockpiling inedible metal in hopes of surviving what’s here now, and what’s coming, is a major (if not potentially fatal) blunder”.

Putin’s Gold … Paradigm, Not

Gold has never been the same since the Derecho of 2020.

In fact, that was the pivot point for both gold and corn which are now, inversely correlated.”

Corn Train Wreck, Continues

“The food supply is, and is going to be destroyed; one way or another.”

… And This, Just Out

As if to drive that last bullet item home, we have:

Turkey Shortage This Fall? | “Bird Flu”

The ‘Right Side’ of The Trade

Being on the right side of the trade means by definition (nearly) everyone else, is on the wrong side.

The last report said that both silver and gold are at The Danger Point®; The location where risk is least for positioning either long or short (not advice not a recommendation).

Based on prior analysis, the expectation is for a continued decline in the precious metals.

Silver Trading ‘Vehicles’

There are many ways to work the silver market.

Several trading vehicles are silver futures (mini futures), silver ETFs, options on ETFs, leveraged bull and bear ETFs and lastly, the physical metal itself.

As of this date (9/18/22), quotes for a typical bag of ‘junk silver’ are below:

SD Bullion

$100 Face Value Bag: $2,006.44

Apmex

$100 Face Value Bag: $2,064.92

Kitco

$100 Face Value Bag: “Out of stock”

This is not an endorsement. The purpose here is to have ‘place-holder’ quote(s) going forward.

Summary

The post is already lengthy.

Next up on the ‘Silver Collapse’, we’ll discuss the other trading vehicles; futures, options, ETFs and leveraged ETFs.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Silver … Cue The Hype

What If Europe Abandons ‘Green Energy?’

The ‘Texas Freeze‘ laid bare the farce that is ‘renewable’ energy.

Will this coming winter do the same for Europe?

Like a limpet on an ocean liner, the ‘silver squeeze’ idea won’t go away.

Here we have yet another report; linked here.

The data in the report’s not in dispute. If that data is to be believed (no reason not to), silver stockpiles are shrinking.

Even so, the major trend-change (down) in silver was identified way back in February of 2021; reports are linked here and here.

The second report stated silver had ‘changed hands’ from strong to weak.

It’s been nearly 20 months since then; silver remains below that February 1st, 2021, level and is down -35.7%, as of Friday’s close.

I like silver as much as the next guy but what we’re discussing here, is strategy.

Silver To Single Digits?

Is that even possible?

Well, was oil going negative possible?

Not until it happened.

The monthly chart of SLV below, has a standard Fibonacci projection shown. Note how at 23.6%, the projection shows price action tapped and reversed down.

Next up is 38.2% at around 13.75, and then 50%, below the 10-area.

Silver SLV, Monthly Chart

Zoom version

And then, a trading channel.

Both silver and gold, are at The Danger Point.

Gold has pushed below support and is currently in Wyckoff spring position.

Silver is below the 20-area, which is established support.

If a rally is in the cards, this is the place to start.

A failure to move decisively higher at this point signals the potential for much lower prices ahead.

Summary

The next update will discuss various tactics that could be used if/when there’s a major downdraft.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Gold Penetrates Support

The ‘Inflation’ Narrative Is False

How do we know the ‘narrative’ is false?

Because the price action tells us at this juncture, we’re in some kind of ‘deflation’ impulse.

Taking it a step further, what happens if we don’t get the much assumed ‘hyperinflation’.

What if something else is afoot?

Remember, a Black Swan can also be an upcoming event that’s widely accepted as fact but does not happen.

Now, to the ‘inflation’ indicator itself: Gold

Gold (GLD) Weekly Close

The downside penetration is clear.

GLD, is at The Danger Point.

If we really do have inflation and gold’s going to launch much higher, the last report stated, penetrating support and setting up a Wyckoff ‘spring’ condition would be a good place to start.

So, here we are.

As this post is being created, GLD is rebounding higher by about +0.50%.

This is normal market behavior.

However, the next chart says gold’s likely to have a hard time moving decisively higher.

On a weekly close basis, gold’s in a confirmed downward channel.

It’s going to take a lot of demand to break out of that trend.

Summary

So, far, the attitude of the ‘average investor’ to gold’s decline is “Good, I’ll just buy more.”

Six months or a year from now, when food supplies have run out or become so expensive, only ‘zee bugs’ will be reasonably priced, one has to wonder if we’ll all have the same attitude.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

There is no ‘Spoon’

Paradigm Shifts

We’re living in the surreal.

Only those who can ‘see’, understand it’s like something out of The Matrix.

The old paradigms no longer apply.

There is no ‘Pivot’

There never was a ‘pivot’; just like there never was a goal of 2% inflation, or full employment.

Way back in 1921, Jesse Livermore pegged it when he told Wyckoff, the whole premise of Wall Street, was to spread “deception”.

Deception is the key.

Attempting to figure out the next earnings release, the CPI or employment numbers, inflation, or what the Fed is likely to do, is to buy into the deception.

Following that deception, is the path of the amateur.

Meanwhile, back on the professional side; as early as 1909, Wyckoff discovered market prices move based on an energy and objective or their own … completely removed from any fundamentals.

A few days ago, this update, discussed how biotech SPBIO, was potentially at a pivot point and ready to reverse lower.

Well, downside reversal is what we have.

Biotech SPBIO, Weekly Close

Even though we still have three trading days left, SPBIO, appears to be confirming the right-side trading channel.

Last Week.

And … this week

With the overall markets down sharply, events appear to be set in motion to continue downside action.

Summary:

As stated in prior updates, the current trade; LABD-22-05, was initiated in anticipation of a significant break lower (not advice, not a recommendation).

On the biotech fundamentals side (not that it matters), the wheels have come off.

The top weighted equities have no P/E … a decent conclusion may be the lower weightings don’t either.

Nobody’s making any money; rates are rising and we’re heading straight into an economic depression.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Gold … Ready To Move

Up or Down ?

Before we get started, no analysis would be complete without the latest mega bull forecasts for gold.

Here they are:

“Everyone Is WRONG About This Cycle” – Peter Schiff

Well, ok. I only have one bullish report.

Since it’s from Schiff, do we really need more? 🙂

Remember, back when it was the Russians that were going to move gold higher? You really can’t make this stuff up.

So, let’s move on and take a look at the truth … the price action for gold (GLD).

Gold (GLD), Daily Close

The un-marked daily chart shows about three-years of price action.

The next chart shows the ‘Changing of Hands’ that was first identified over four months ago in this post.

Also shown is the current (channel) trendline that appears to be in effect; GLD, is ‘respecting’ the line.

The left side channel line is grey in color so that multiple hits are shown more clearly.

However, the next chart is where it gets interesting.

If or when GLD penetrates support, it would by definition be set-up in Wyckoff ‘spring position’.

If GLD, was going to launch to new all-time highs, getting itself into ‘spring position’ would be an excellent place to start the move.

If and when there’s penetration of support, one thing to watch closely is the volume.

Would it be another high volume ‘changing of hands’ (for the upside) or a low volume affair that grinds on down.

Summary

From a fundamental standpoint, where’s the money going to come from to increase the demand for gold?

We’re already at the front end of (very likely) the largest real estate crash in U.S. history.

The consumer’s tapped out with record high credit card debt; mass layoffs have already started.

Bankruptcies in some areas are up over 100% from last year. Bankruptcy means ‘liquidation’ and that includes any precious metals.

Anything can happen and gold could rally.

However, the backdrop of demand destruction and asset collapse, suggest the direction for gold continues to be to lower levels.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

The ‘Santa Claus’ Rally

That Was it!

It’s going to be a very different place come December.

This won’t be like ’08 -’09, where all the stops are being pulled to ‘rescue’ the market.

No, this time really is different.

We can all see by now; the plan is controlled demolition.

Paraphrasing Jerimiah Babe, and Pinball Preparedness, we haven’t even got started (with the collapse) and the public’s already folding up.

What’s it going to be like when it really hits?

This past week, all the major indices have gone through some type of relief rally. Call it a Santa Claus rally because there probably won’t be one this December.

Trading Consistency

Throughout this upward correction, the case has been made over and again, only biotech SPBIO’s in a technical (and fundamental) condition that would allow it to decline farthest and fastest (not advice, not a recommendation).

Wyckoff analysis along with Livermore’s strategic approach that’s coupled with Loeb’s ‘focus’, has led us to (shorting) this sector exclusively.

Strategy, Tactics, Focus

Biotech SPBIO, Weekly Close

Looking at the far-right side of the chart, SPBIO rallied this past week. It looks like it may head higher … that is, until we put in the trend-lines.

Now, let’s put in the trendlines.

Extended trendlines show the downside potential.

We’re about to see how this works out.

Friday’s upward action in SPBIO slowed with inverse LABD, posting narrow (downside) action as well.

Ready to reverse.

Summary

Trading action in the past week amounted to reducing the position size in LABD-22-05, by about 4.6% (not advice, not a recommendation).

If and when SPBIO continues is downward trajectory, that position (shorting via LABD) will again be increased as the market allows.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

We’ve Seen This Movie, Before

1907, 1929, 1974, 1987, 2000, 2007, … and Now

As Scott Walters has said:

It’s different this time.

It’s Worse!

That ‘worse’ part includes the adverse moves in the market.

This time around, as opposed to ’07 – ’08, they really do seem to be worse.

Which, brings us to biotech SPBIO.

Biotech SPBIO, Weekly

Just to remind ourselves where biotech is at the moment, we have the un-marked weekly chart.

This sector’s the only one (miners excluded) that’s trading below the 50-Week and 200 Week Moving Averages with a 50-wk cross to the downside.

On a weekly basis, we’re in a major long-term downtrend that looks to have finished its upside correction.

Getting closer-in on the hourly chart we have the following.

SPBIO, Hourly

What do you see?

Here’s the marked-up version.

Over and again; a fractal set-up called ‘Spring-to-Up-Thrust‘.

The zoom chart below shows that price action appears to be struggling at the resistance area (black line).

Danger Point

At this juncture we’re at The Danger Point®

Enough of a push higher and SPBIO, could continue on upward, overcoming significant technical and fundamental barriers.

However, since we’re trending lower in the longer timeframes, probabilities suggest that downtrend may be ready (or near ready) to re-assert itself.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech (Short), The Details

Relentless Positioning For The Downside

Like a terrier on a mailman’s leg, positioning short biotech via LABD, has been relentless (not advice, not a recommendation).

This update details the current positioning via 3X, Leveraged Inverse Fund, LABD.

This is not investment advice; this site has no obligation to provide the following information.

However, as stated in the About section, one of the purposes here, is to document trade actions and results.

With that in mind, the green arrows show the locations of LABD entries for the short-biotech (SBPBIO) trade identified as LABD-22-05.

Biotech SPBIO, 3X Leveraged Inverse Fund LABD, Daily

The magenta arrow at the far right of the chart, is the ‘break-even’ point. It’s about 1.75 – 2.0 points away from the current price.

Note: This is not ‘Dollar Cost Averaging’.

Few in the industry know that ‘dollar cost averaging’ is based on a scam conducted by the bucket shops in the early 1900s.

It’s comforting to know, that method (the scam), has made its way into at least one SEC certification requirement.

There, I feel much better 🙂

One of, if not the main reason for working this trade with the current method, is the real danger this market could ‘implode’ at any minute.

We’re just one (un)planned event away from being down 20% – 50% overnight.

Biotech SPBIO ($SPSIBI), Weekly Close

The weekly close shows SPBIO to be unique among all the major indices (miners excluded).

Not even the sister index IBB, has the weekly MA cross (black arrow) to the downside.

“You Are Here”

On the chart below, the complete positioning short SPBIO is shown as the magenta rectangle.

Also shown, are measured move targets.

Looking at the potential of this trade, the reason for the dogged persistence becomes clear.

Summary

As always, anything can happen … the trade could fall apart.

That’s true.

However, probabilities for continued market downside are increasing, not decreasing.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279

Biotech … Possibly, FATE(AL)

Trend-Lining @ -99%, Annualized

Is biotech about to go ‘flat-line’?

It’s not just biotech.

As The Maverick of Wall St. presents in his latest video, linked herethe entire market is poised for its next leg down.

In that video, estimates for that next leg are anywhere from -30% to -90%.

Fate Therapeutics FATE, Daily

FATE, is one of our ‘three amigos‘ of the sector, SPBIO.

The daily chart shows a confirmed, multi-hit trend line that’s declining at over -99%, annualized

FATE, isn’t the only one in the ‘- 99%’, crowd

TWST, is also trending lower at -99%, and BEAM, is running a close second at -98%, annualized.

Summary

Today, Friday (mid-session), is the last trading day before a holiday weekend.

During such days, we typically have an upward (low volume) bias.

With that, there’s still just a bit more trading room for FATE to contact the right side trendline.

Of course, what happens next will be the important part.

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279